XOMA Trademark

Trademark Overview

On Monday, July 30, 2018, a trademark application was filed for XOMA with the United States Patent and Trademark Office. The USPTO has given the XOMA trademark a serial number of 88058495. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 14, 2025. This trademark is owned by XOMA (US) LLC. The XOMA trademark is filed in the Insurance & Financial Services category with the following description:

Financing related to intellectual property portfolios; financing of pharmaceutical, drug, and medical device development
xoma

General Information

Serial Number88058495
Word MarkXOMA
Filing DateMonday, July 30, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 14, 2025
Registration Number5765645
Registration DateTuesday, May 28, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 25, 2018

Trademark Statements

Description of MarkThe mark consists of the word "XOMA" in stylized form, with a curved line extending from the letter "X" over the letter "O" and a solid triangle inside the letter "A".
Goods and ServicesFinancing related to intellectual property portfolios; financing of pharmaceutical, drug, and medical device development
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, August 4, 2018
Primary Code036
First Use Anywhere DateMonday, August 20, 2018
First Use In Commerce DateMonday, August 20, 2018

Trademark Owner History

Party NameXOMA (US) LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 94608
Party NameXOMA (US) LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 94608
Party NameXOMA (US) LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Thursday, November 15, 2018ASSIGNED TO EXAMINER
Thursday, November 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 25, 2018PUBLISHED FOR OPPOSITION
Tuesday, December 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 2, 2018NEW APPLICATION ENTERED
Saturday, August 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 7, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 19, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 1, 2019TEAS STATEMENT OF USE RECEIVED
Monday, April 1, 2019USE AMENDMENT FILED
Thursday, April 18, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, April 20, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, January 6, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, January 6, 2023WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, January 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 25, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 19, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 14, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 14, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 28, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 28, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 25, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

xoma financing medical device development drug portfolios related intellectual property pharmaceutical